428 filings
Page 3 of 22
D
zmk6gfzt4cs
13 Sep 23
$13.55 mm in equity / options / securities to be acquired, sold $13.55 mm, 1 investor
4:45pm
8-K
hbdgchrs10 h0
6 Sep 23
NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting
8:30am
8-K
m465u2tt
1 Sep 23
NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
4:30pm
8-K
04652hsc7le6
30 Aug 23
NanoVibronix Cites Positive Results from Independent Testing of UroShield
8:30am
8-K
gduq6dh1vao74u7
29 Aug 23
Regulation FD Disclosure
4:05pm
8-K
wlmym
28 Aug 23
NanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff
8:30am
8-K
ywp25k1d1 5k
23 Aug 23
NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plus
4:45pm
EFFECT
36tpcovt
14 Aug 23
Notice of effectiveness
12:15am
CORRESP
hq3vqeyp
9 Aug 23
Correspondence with SEC
12:00am
UPLOAD
h1x 8sybc70h
9 Aug 23
Letter from SEC
12:00am
8-K
7loanpfe
20 Jul 23
Other Events
4:45pm
8-K
waxnnm9wvu8hqwt6o9
21 Jun 23
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
9crfgsg5j2l
14 Jun 23
NanoVibronix Announces Distribution Agreement with Sports Medicine Supplier Mio-Guard
8:30am
8-K
50gwo6j maidkc
25 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
DEFA14A
f33rvntl un6v
18 May 23
Additional proxy soliciting materials
8:32am